10 participants
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-11-18
- Start Date:
- 2022-05-20
- Completion:
- 2026-07-01
Conditions
- Hepatocellular Carcinoma
Interventions
- DRUG
No Results Yet